The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Peritoneal Cavity Regulatory B Cells (B10 Cells) Modulate IFN-γ+CD4+ T Cell Numbers during Colitis Development in Mice
Open accessAbstract
The spleen regulatory B cell subset with the functional capacity to express IL-10 (B10 cells) modulates both immune responses and autoimmune disease severity. However, the peritoneal cavity also contains relatively high frequencies of functionally defined IL-10–competent B10 cells. In this study, peritoneal cavity B10 cells shared similar cell surface phenotypes with their spleen counterparts. However, peritoneal cavity B10 cells were 10-fold more frequent among B cells than occurred within the spleen, intestinal tract, or mesenteric lymph nodes and were present at higher proportions among the phenotypically defined peritoneal B1a > B1b > B2 cell subpopulations. The development or localization of B10 cells within the peritoneal cavity was not dependent on the presence of commensal microbiota, T cells, IL-10 or B10 cell IL-10 production, or differences between their fetal liver or adult bone marrow progenitor cell origins. The BCR repertoire of peritoneal cavity B10 cells was diverse, as occurs in the spleen, and predominantly included germline-encoded VH and VL regions commonly found in either the conventional or B1 B cell compartments. Thereby, the capacity to produce IL-10 appears to be an intrinsic functional property acquired by clonally diverse B cells. Importantly, IL-10 production by peritoneal cavity B cells significantly reduced disease severity in spontaneous and induced models of colitis by regulating neutrophil infiltration, colitogenic CD4+ T cell activation, and proinflammatory cytokine production during colitis onset. Thus, the numerically small B10 cell subset within the peritoneal cavity has regulatory function and is important for maintaining homeostasis within gastrointestinal tissues and the immune system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“The proportion of Bregs ranges from 1 to 3% of total B cells in the spleen and peritoneal cavity of healthy mice, whereas in humans, Bregs typically constitute 1 -4% of circulating B cells under homeostatic conditions [57,59,60].”
From Is there a role for B cells in Alzheimer's disease? (2026) · cites this paper as [60]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737 · cited 2×
“T cells, B cells, monocytes, macrophages, mast cells, and eosinophils can all secrete IL-10 that suppresses inflammatory cytokine production, Th1/Th2 polarization, and Ag presentation (5, 13, 14).”
BackgroundThe gut microbiota shapes intestinal immune responses during health and disease
Round, J. L., & Mazmanian, S. K. (2009) · Nature Reviews Immunology · doi:10.1038/nri2515 · Cited by 5,029 · cited 7×
“Given that T cells also play critical regulatory roles during IBD development in mice, as well as in humans (1, 3), it is likely that B10 and regulatory Foxp3+ CD4+ T cells share complementary regulatory functions for IBD, as previously shown for experimental autoimmune encephalomyelitis (29).”
BackgroundInfluentialMultiple sequence alignment with the Clustal series of programs
Chenna, R. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg500 · Cited by 4,905 · cited 1×
“VH-D-JH and VK-JK transcript alignments and phylogenetic trees based on average percent identity were constructed using ClustalW2 (45).”
MethodInterleukin-10-deficient mice develop chronic enterocolitis
Kühn, R., Löhler, J., Rennick, D. M., Rajewsky, K., & Müller, W. (1993) · Cell · doi:10.1016/0092-8674(93)80068-p · Cited by 4,248
RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement
Shinkai, Y. (1992) · Cell · doi:10.1016/0092-8674(92)90029-c · Cited by 2,651 · cited 1×
“Rag2 and 10BiT reporter mice were as described (39, 40).”
MethodIL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells
Fiorentino, D. F., Zlotnik, A., Vieira, P., Mosmann, T. R., Howard, M., Moore, K. W., & O’Garra, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.10.3444 · Cited by 1,866 · cited 1×
“T cells, B cells, monocytes, macrophages, mast cells, and eosinophils can all secrete IL-10 that suppresses inflammatory cytokine production, Th1/Th2 polarization, and Ag presentation (5, 13, 14).”
BackgroundAsseman, C., Mauze, S., Leach, M. W., Coffman, R. L., & Powrie, F. M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.7.995 · Cited by 1,617 · cited 2×
“That peritoneal cavity B10 cells can alter the development and severity of colitis was further verified using the inducible T cell– transfer model of colitis (10).”
BackgroundRegulatory T Cell-Derived Interleukin-10 Limits Inflammation at Environmental Interfaces
Rubtsov, Y. P., Rasmussen, J. P., Chi, E. Y., Fontenot, J., Castelli, L., Ye, X., Treuting, P., Siewe, L., Roers, A., Henderson, W. R., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.02.017 · Cited by 1,586
Blair, P. A., Noreña, L. Y., Flores-Borja, F., Rawlings, D. J., Isenberg, D. A., Ehrenstein, M. R., & Mauri, C. (2010) · Immunity · doi:10.1016/j.immuni.2009.11.009 · Cited by 1,574 · cited 1×
“B10 cells represent a small and functionally distinct B cell subset that shares some overlapping phenotypic markers with multiple B cell subpopulations, including spleen B1 cells, marginal zone progenitor cells, marginal zone cells, memory cells and plasmablasts (23, 24, 46, 51-53).”
Backgroundvon Büdingen, H. ‐., Palanichamy, A., Lehmann‐Horn, K., Michel, B., & Zamvil, S. S. (2015) · European Neurology · doi:10.1159/000377675 · Cited by 1,475
Yanaba, K., Bouaziz, J., Haas, K. M., Poe, J. C., Fujimoto, M., & Tedder, T. F. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.017 · Cited by 1,233
Self-citationBrochet, X., Lefranc, M., & Giudicelli, V. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn316 · Cited by 1,220 · cited 1×
“Productive Ig rearrangements were compared against germline Ig sequences, according to the Ig Basic Local Alignment Search Tool database (National Center for Biotechnology Information, Bethesda, MD), and analyzed using the Immunogenetics V-query and Standardization tool (44) to determine V(D)J gene family usage.”
MethodPowrie, F., Leach, M. W., Mauze, S., Menon, S., Barcomb Caddle, L., & Coffman, R. L. (1994) · Immunity · doi:10.1016/1074-7613(94)90045-0 · Cited by 1,146
Iwata, Y., Matsushita, T., Horikawa, M., DiLillo, D. J., Yanaba, K., Venturi, G. M., Szabolcs, P., Bernstein, S. H., MAGRO, C. M. J., Williams, A. D., et al. (2010) · Blood · doi:10.1182/blood-2010-07-294249 · Cited by 1,107 · cited 5×
“Consistent with their in vivo Ag stimulation, spleen B10 cells are hyper-responsive to mitogens (23, 28) and can give rise to Ag-specific, self-reactive or natural antibodies (46).”
BackgroundInfluentialSelf-citationMizoguchi, A., Mizoguchi, E., Takedatsu, H., Blumberg, R. S., & Bhan, A. K. (2002) · Immunity · doi:10.1016/s1074-7613(02)00274-1 · Cited by 978 · cited 9×
“Given that T cells also play critical regulatory roles during IBD development in mice, as well as in humans (1, 3), it is likely that B10 and regulatory Foxp3+ CD4+ T cells share complementary regulatory functions for IBD, as previously shown for experimental autoimmune encephalomyelitis (29).”
BackgroundInfluentialInterleukin-10 Therapy—Review of a New Approach
Asadullah, K., Sterry, W., & Volk, H. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.2.4 · Cited by 941 · cited 1×
“T cells, B cells, monocytes, macrophages, mast cells, and eosinophils can all secrete IL-10 that suppresses inflammatory cytokine production, Th1/Th2 polarization, and Ag presentation (5, 13, 14).”
BackgroundRegulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression
Matsushita, T., Yanaba, K., Bouaziz, J., Fujimoto, M., & Tedder, T. F. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36030 · Cited by 909 · cited 3×
“Human and mouse B10 cell IL-10 production is central to their ability to negatively regulate innate and Ag-specific adaptive immune responses as well as inflammation and autoimmune disease (23-25, 28-33).”
BackgroundSelf-citationMurai, M., Turovskaya, O., Kim, G., Madan, R., Karp, C. L., Cheroutre, H., & Kronenberg, M. (2009) · Nature Immunology · doi:10.1038/ni.1791 · Cited by 851 · cited 1×
“Mice deficient in IL10, a potent immunoregulatory cytokine with anti-inflammatory properties (5), are highly susceptible to chronic enterocolitis that is spontaneously triggered by intestinal microbiota (6, 7).”
BackgroundHe, B., Xu, W., Santini, P. A., Polydorides, A. D., Chiu, A., Estrella, J. S., Shan, M., Chadburn, A., Villanacci, V., Plebani, A., et al. (2007) · Immunity · doi:10.1016/j.immuni.2007.04.014 · Cited by 748 · cited 1×
“Although the induction of colitis requires both spontaneous and Ag-specific T cell proliferation, driven in part by microbiota-derived innate signals (1, 70, 71), the intestinal microbiota also trigger innate immune responses that can modify the T cell compartment and prevent IBD (20, 70, 72).”
BackgroundRegulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions
Yoshizaki, A., Miyagaki, T., DiLillo, D. J., Matsushita, T., Horikawa, M., Kountikov, E. I., Spolski, R. J., Poe, J. C., Leonard, W. J., & Tedder, T. F. (2012) · Nature · doi:10.1038/nature11501 · Cited by 657 · cited 18×
“LPS was added to the 5-h PMA, ionomycin, and monensin (PIM)-stimulated cultures because it marginally enhances B10 cell enumeration (28).”
BackgroundInfluentialSelf-citationHaas, K. M., Poe, J. C., Steeber, D. A., & Tedder, T. F. (2005) · Immunity · doi:10.1016/j.immuni.2005.04.011 · Cited by 628 · cited 1×
“2A-B) that are functionally distinct (48).”
Self-citationMaynard, C. L., Harrington, L. E., Janowski, K. M., Oliver, J. R., Zindl, C. L., Rudensky, A. Y., & Weaver, C. T. (2007) · Nature Immunology · doi:10.1038/ni1504 · Cited by 599
Self-citationthe IBSEN study group, Franke, A., Balschun, T. C., Karlsen, T. H., Skiecevičienė, J., Nikolaus, S., Gabriele Mayr, B., Domingues, F. S., Albrecht, M., Nothnagel, M., et al. (2008) · Nature Genetics · doi:10.1038/ng.221 · Cited by 590 · cited 1×
“Human IBD is also genetically linked with il10 locus polymorphisms or altered serum IL-10 concentrations (11, 12).”
BackgroundMizoguchi, A., & Bhan, A. K. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.2.705 · Cited by 580
Ly‐1 B (B‐1) cells are the main source of B cell‐derived interleukin 10
O’Garra, A., Chang, R., Go, N. F., Hastings, R., Haughton, G., & Howard, M. (1992) · European Journal of Immunology · doi:10.1002/eji.1830220314 · Cited by 525
Yanaba, K., Bouaziz, J.-D., Matsushita, T., Tsubata, T., & Tedder, T. F. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900270 · Cited by 503 · cited 10×
“LPS was added to the 5-h PMA, ionomycin, and monensin (PIM)-stimulated cultures because it marginally enhances B10 cell enumeration (28).”
BackgroundMethodInfluentialSelf-citationDing, Q., Yeung, M., Camirand, G., Zeng, Q., Akiba, H., Yagita, H., Chalasani, G., Sayegh, M. H., Najafian, N., & Rothstein, D. M. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46274 · Cited by 462 · cited 1×
“Receptors or pathways that positively or negatively regulate BCR signaling such as CD19, CD22 and CD40 can also significantly modulate B10 cell numbers (28, 54-57).”
BackgroundDiLillo, D. J., Matsushita, T., & Tedder, T. F. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05137.x · Cited by 445 · cited 3×
“1) or within the spleen or peripheral lymph nodes (26).”
BackgroundSelf-citationMatsushita, T., Horikawa, M., Iwata, Y., & Tedder, T. F. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001307 · Cited by 394 · cited 2×
“Adoptively transferred peritoneal cavity B10 cells can also regulate skin inflammation during contact hypersensitivity responses (37), and B10 cell numbers expand significantly within the CNS during experimental autoimmune encephalomyelitis (29).”
Self-citationKamanaka, M., Kim, S. T., Wan, Y. Y., Sutterwala, F. S., Lara-Tejero, M., Galán, J. E., Harhaj, E., & Flavell, R. A. (2006) · Immunity · doi:10.1016/j.immuni.2006.09.013 · Cited by 392 · cited 2×
“Tiger mice have an IRES-GFP element inserted following the il10 locus (38).”
BackgroundSuppressive Role of B Cells in Chronic Colitis of T Cell Receptor α Mutant Mice
Mizoguchi, A., Mizoguchi, E., Smith, R. N., Preffer, F. I., & Bhan, A. K. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.10.1749 · Cited by 345
Neves, P., Lampropoulou, V., Calderón‐Gómez, E., Roch, T., Stervbo, U., Shen, P., Kühl, A. A., Loddenkemper, C., Haury, M., Nedospasov, S. A., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.10.016 · Cited by 327 · cited 1×
“B10 cells represent a small and functionally distinct B cell subset that shares some overlapping phenotypic markers with multiple B cell subpopulations, including spleen B1 cells, marginal zone progenitor cells, marginal zone cells, memory cells and plasmablasts (23, 24, 46, 51-53).”
BackgroundIL-10-producing regulatory B cells (B10 cells) in autoimmune disease
Kalampokis, I., Yoshizaki, A., & Tedder, T. F. (2013) · Arthritis Research & Therapy · doi:10.1186/ar3907 · Cited by 316 · cited 9×
“Spleen B10 cells are predominantly found within the minor CD1dhiCD5+ B cell subpopulation along with B10 progenitor (B10pro) cells that are induced to acquire IL-10 competence during in vitro culture with agonistic CD40 mAb or LPS (28, 30, 32).”
BackgroundInfluentialSelf-citationRegulation of B1 cell migration by signals through Toll-like receptors
Ha, S.-A., Tsuji, M., Suzuki, K., Meek, B., YASUDA, N., Kaisho, T., & Fagarasan, S. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061041 · Cited by 301 · cited 2×
“However, peritoneal B cells can also migrate into the periphery under certain conditions or following stimulation, particularly through TLRs (65).”
BackgroundInterleukin-23/Th17 pathways and inflammatory bowel disease
Abraham, C., & Cho, J. H. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20894 · Cited by 294 · cited 1×
“Th1 and Th17 cells are major disease contributors in both the IL-10-deficient (IL-10−/−) mouse model of spontaneous disease and the CD4+ T cell-induced model of colitis, with IFN-γ– and IL-17-competent T cells detectable at all stages of disease in mice and humans (1-4).”
BackgroundBlair, P. A., Chávez-Rueda, A. K., Evans, J. G., Shlomchik, M. J., Eddaoudi, A., Isenberg, D. A., Ehrenstein, M. R., & Mauri, C. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803052 · Cited by 291 · cited 1×
“B10 cells represent a small and functionally distinct B cell subset that shares some overlapping phenotypic markers with multiple B cell subpopulations, including spleen B1 cells, marginal zone progenitor cells, marginal zone cells, memory cells and plasmablasts (23, 24, 46, 51-53).”
BackgroundMatsumoto, M., Fujii, Y., Baba, A., Hikida, M., Kurosaki, T., & Baba, Y. (2011) · Immunity · doi:10.1016/j.immuni.2011.03.016 · Cited by 279 · cited 1×
“Receptors or pathways that positively or negatively regulate BCR signaling such as CD19, CD22 and CD40 can also significantly modulate B10 cell numbers (28, 54-57).”
BackgroundExacerbation of ulcerative colitis after rituximab salvage therapy
Goetz, M., Atreya, R. N., Ghalibafian, M., Galle, P. R., & Neurath, M. F. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20215 · Cited by 268 · cited 2×
“Mature B cell depletion in humans with ulcerative colitis using CD20 mAb was ineffective in a placebo-controlled study (15), and has even been suggested to exacerbate colonic inflammation in some patients (16, 17).”
BackgroundSato, S., Ono, N., Steeber, D. A., Pisetsky, D. S., & Tedder, T. F. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.10.4371 · Cited by 267 · cited 1×
“For immunofluorescence analysis, single-cell leukocyte suspensions (1 3 10(6) cells) were stained on ice for 20–30 min using predetermined optimal concentrations of mAbs, as described (41).”
MethodSelf-citationRay, A., Basu, S., Williams, C. B., Salzman, N. H., & Dittel, B. N. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103354 · Cited by 258 · cited 1×
“fined in humans and mice by their ability to express IL-10 following 5 h of ex vivo phorbol ester and ionomycin stimulation (23–25), which distinguishes them from regulatory B cells that modulate immune responses through other mechanisms (26, 27).”
BackgroundHardy, R. R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.5.2749 · Cited by 249
Xiu, Y., Wong, C. P., Bouaziz, J., Hamaguchi, Y., Wang, Y., Pop, S. M., Tisch, R., & Tedder, T. F. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.5.2863 · Cited by 230
Self-citationFeng, T., Wang, L., Schoeb, T. R., Elson, C. O., & Cong, Y. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20092253 · Cited by 218 · cited 7×
“Given that T cells also play critical regulatory roles during IBD development in mice, as well as in humans (1, 3), it is likely that B10 and regulatory Foxp3+ CD4+ T cells share complementary regulatory functions for IBD, as previously shown for experimental autoimmune encephalomyelitis (29).”
BackgroundInfluentialIntestinal Effector T Cells in Health and Disease
Maynard, C. L., & Weaver, C. T. (2009) · Immunity · doi:10.1016/j.immuni.2009.08.012 · Cited by 215 · cited 3×
“C hronic inflammatory disorders of the intestine are collectively referred to as inflammatory bowel disease (IBD), with ulcerative colitis and Crohn’s disease being the most prevalent in humans (1).”
BackgroundSelf-citationAn unbiased analysis of V(H)-D-J(H) sequences from B-1a, B-1b, and conventional B cells
Kantor, A. B., Merrill, C., Herzenberg, L. A., & Hillson, J. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.3.1175 · Cited by 209 · cited 2×
“Thereby, peritoneal cavity B10 cell VH use was similar to that observed for spleen B10 cells (46) and conventional B cells (49), but it also included sequences commonly associated with peritoneal cavity B1 cells (58, 59).”
BackgroundResultRegulatory role of mature B cells in a murine model of inflammatory bowel disease
Mizoguchi, E., Mizoguchi, A., Preffer, F. I., & Bhan, A. K. (2000) · International Immunology · doi:10.1093/intimm/12.5.597 · Cited by 206
Regulatory B cell production of IL-10 inhibits lymphoma depletion during CD20 immunotherapy in mice
Horikawa, M., Minard‐Colin, V., Matsushita, T., & Tedder, T. F. (2011) · Journal of Clinical Investigation · doi:10.1172/jci59266 · Cited by 200 · cited 1×
“Human and mouse B10 cell IL-10 production is central to their ability to negatively regulate innate and Ag-specific adaptive immune responses as well as inflammation and autoimmune disease (23-25, 28-33).”
BackgroundSelf-citationHardy, R. R., Carmack, C. E., Shinton, S. A., Riblet, R. J., & Hayakawa, K. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.10.3643 · Cited by 192
Arnold, L. W., Pennell, C. A., McCray, S., & Clarke, S. H. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.5.1585 · Cited by 186 · cited 1×
“VH3 and VH12 were the most frequently observed VH families, consistent with the predominance of these families within the B1 cell repertoire (49, 50).”
BackgroundWei, B., Velázquez, P., Turovskaya, O., Spricher, K., Aranda, R., Kronenberg, M., Birnbaumer, L., & Braun, J. G. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409449102 · Cited by 182 · cited 1×
“In studies by other investigators, mesenteric lymph node B cells, in combination with CD8 T cells, protected mice from colitis induced by Gai2 CD4 T cells through the formation of regulatory T cells (68).”
ResultMaseda, D., Smith, S. H., DiLillo, D. J., Bryant, J. M., Candando, K. M., Weaver, C. T., & Tedder, T. F. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1102500 · Cited by 180 · cited 9×
“Lymphocytes were isolated on day 3 or 7 and assayed for reporter protein expression, as described (46).”
BackgroundMethodResultInfluentialSelf-citationIL-10–Producing Regulatory B10 Cells Inhibit Intestinal Injury in a Mouse Model
Yanaba, K., Yoshizaki, A., Asano, Y., Kadono, T., Tedder, T. F., & Sato, S. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2010.10.022 · Cited by 179 · cited 3×
“The adoptive transfer of spleen B10 cells dramatically reduces DSS-induced colon inflammation in CD19 mice, which are B10 cell deficient (22).”
BackgroundMethodInfluentialSelf-citationRandomised placebo-controlled trial of rituximab (anti-CD20) in active ulcerative colitis
Leiper, K., Martin, K., Ellis, A., Subramanian, S., Watson, A. J. M., Christmas, S. E., Howarth, D., Campbell, F., & Rhodes, J. M. (2011) · Gut · doi:10.1136/gut.2010.225482 · Cited by 178 · cited 2×
“Mature B cell depletion in humans with ulcerative colitis using CD20 mAb was ineffective in a placebo-controlled study (15), and has even been suggested to exacerbate colonic inflammation in some patients (16, 17).”
BackgroundAsseman, C., Read, S., & Powrie, F. M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.2.971 · Cited by 172 · cited 1×
“Continuous rIL-10 treatment attenuates pathology in the T cell–transfer model of colitis following the adoptive transfer of CD25(2)CD45RBCD4 T cells into lymphocyte-deficient Rag2 mice (4, 9, 10).”
BackgroundUlcerative colitis following B lymphocyte depletion with rituximab in a patient with Graves’ disease
Fassi, D. E., Nielsen, C. H., Kjeldsen, J., Clemmensen, O. J., & Hegedűs, L. D. (2008) · Gut · doi:10.1136/gut.2007.138305 · Cited by 170 · cited 2×
“Mature B cell depletion in humans with ulcerative colitis using CD20 mAb was ineffective in a placebo-controlled study (15), and has even been suggested to exacerbate colonic inflammation in some patients (16, 17).”
BackgroundFetal B-cell lymphopoiesis and the emergence of B-1-cell potential
Dorshkind, K. A., & Montecino‐Rodriguez, E. (2007) · Nature reviews. Immunology · doi:10.1038/nri2019 · Cited by 159 · cited 1×
“The cellular origin of B10 cells is unknown, while the origin of CD5+ B1 cells has been a matter of debate for over 30 years (62, 63).”
BackgroundProtective and Pathogenic Roles for B Cells during Systemic Autoimmunity in NZB/W F1 Mice
Haas, K. M., Watanabe, R., Matsushita, T., Nakashima, H., Ishiura, N., Okochi, H., Fujimoto, M., & Tedder, T. F. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902391 · Cited by 152 · cited 13×
“LPS was added to the 5-h PMA, ionomycin, and monensin (PIM)-stimulated cultures because it marginally enhances B10 cell enumeration (28).”
BackgroundInfluentialSelf-citationProstaglandin E2 and SOCS1 have a role in intestinal immune tolerance
Chinen, T., Komai, K., Muto, G., Morita, R., Inoue, N., Yoshida, H., Sekiya, T., Yoshida, R., Nakamura, K., Takayanagi, R., et al. (2011) · Nature Communications · doi:10.1038/ncomms1181 · Cited by 125 · cited 1×
“A modified scoring system was used to evaluate histological changes based on three parameters of disease, as described (47).”
MethodHorikawa, M., Weimer, E. T., DiLillo, D. J., Venturi, G. M., Spolski, R. J., Leonard, W. J., Heise, M. T., & Tedder, T. F. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201427 · Cited by 123 · cited 2×
“autoimmune encephalomyelitis and during Listeria infections (32, 33).”
BackgroundSelf-citationIdentifying Regulatory B Cells (B10 Cells) that Produce IL-10 in Mice
Matsushita, T., & Tedder, T. F. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-869-0_7 · Cited by 116 · cited 1×
“Because functionally matured B10pro cells and ex vivo B10 cells both express IL-10 after these cultures, B10+B10pro cell frequencies are measured (42).”
BackgroundSelf-citationRegulatory role of B-1 B cells in chronic colitis
Shimomura, Y., Mizoguchi, E., Sugimoto, K., Kibe, R., Benno, Y., Mizoguchi, A., & Bhan, A. K. (2008) · International Immunology · doi:10.1093/intimm/dxn031 · Cited by 111 · cited 1×
“Mizoguchi and colleagues (67) recently demonstrated a regulatory role for peritoneal cavity B1 cells from TCRa mice during chronic colitis, possibly through generating natural Abs in response to microbial flora.”
BackgroundA differentiation pathway for B1 cells in adult bone marrow
Esplin, B. L., Welner, R. S., Zhang, Q., Borghesi, L., & Kincade, P. W. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811632106 · Cited by 105 · cited 1×
“Although the fetal liver was once thought to be the exclusive source of B1 cells, adult bone marrow precursor cells can become fully functional CD5 cells in adult mice (64).”
BackgroundB cell-derived IL-10 suppresses inflammatory disease in Lyn-deficient mice
Scapini, P., Lamagna, C., Hu, Y., Lee, K., Tang, Q., DeFranco, A. L., & Lowell, C. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1107913108 · Cited by 84 · cited 1×
“Receptors or pathways that positively or negatively regulate BCR signaling such as CD19, CD22 and CD40 can also significantly modulate B10 cell numbers (28, 54-57).”
BackgroundIL‐10 Production by CD5 B Cells
O'GARRA, A., & HOWARD, M. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb24615.x · Cited by 74 · cited 1×
“Spontaneous ex vivo secretion of IL-10 by peritoneal cavity B cells has been well described (36, 60), with B1a, B1b, and B2 cells variably contributing to IL-10 secretion in vitro (Fig.”
BackgroundFillatreau, S. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00991.x · Cited by 72 · cited 1×
“Thus, spontaneous ex vivo IL-10 production by peritoneal cavity B10 cells may reflect their prior in vivo interactions with T cells, although it remains possible that innate- or pathogeninduced signals may also induce B10 cell IL-10 production in vivo (46, 61).”
BackgroundThe peritoneal micromilieu commits B cells to home to body cavities and the small intestine
Berberich, S., Förster, R., & Pabst, O. (2007) · Blood · doi:10.1182/blood-2006-12-064345 · Cited by 71 · cited 1×
“3A) (69), B10 cells may be functionally important both centrally within the spleen and within the peritoneal cavity and GALTs during colitis.”
BackgroundAmplified B Lymphocyte CD40 Signaling Drives Regulatory B10 Cell Expansion in Mice
Poe, J. C., Smith, S. H., Haas, K. M., Yanaba, K., Tsubata, T., Matsushita, T., & Tedder, T. F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022464 · Cited by 70 · cited 1×
“Receptors or pathways that positively or negatively regulate BCR signaling such as CD19, CD22 and CD40 can also significantly modulate B10 cell numbers (28, 54-57).”
BackgroundSelf-citationFrequent occurrence of identical heavy and light chain Ig rearrangements
Seidl, K. (1997) · International Immunology · doi:10.1093/intimm/9.5.689 · Cited by 62 · cited 1×
“Thereby, peritoneal cavity B10 cell VH use was similar to that observed for spleen B10 cells (46) and conventional B cells (49), but it also included sequences commonly associated with peritoneal cavity B1 cells (58, 59).”
ResultNakashima, H., Hamaguchi, Y., Watanabe, R., Ishiura, N., Kuwano, Y., Okochi, H., Takahashi, Y., Tamaki, K., Sato, S., Tedder, T. F., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901719 · Cited by 55 · cited 10×
“The mAbs used in this study are as follows: CD21/35 (7G6), CD23 (B3B4), CD24 (M1/69), CD25 (PC61), CD38 (90/CD38), CD43 (S7), CD44 (IM7), CD138 (281-2), and CD11b (M1/70) (all from BD Pharmingen, San Diego, CA); IgM (11/41), CD4 (GK1.”
BackgroundInfluentialSelf-citationRohatgi, S., Ganju, P., & Sehgal, D. (2008) · Journal of Immunological Methods · doi:10.1016/j.jim.2008.09.017 · Cited by 48 · cited 1×
“cDNA was synthesized, and Ig H and L chain transcripts were amplified using nested PCR primers, as described (43).”
MethodAithal, G. P., Craggs, A., Day, C. P., Welfare, M., Daly, A. K., Mansfield, J. C., & Hudson, M. (2001) · Digestive Diseases and Sciences · doi:10.1023/a:1010604307776 · Cited by 42 · cited 1×
“Human IBD is also genetically linked with il10 locus polymorphisms or altered serum IL-10 concentrations (11, 12).”
BackgroundNemoto, Y., Kanai∥, T., Kameyama, K., Shinohara, T., Sakamoto, N., Totsuka, T., Okamoto, R., Tsuchiya, K., Nakamura, T., Sudo, T., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803684 · Cited by 36 · cited 1×
“Given that T cells also play critical regulatory roles during IBD development in mice, as well as in humans (1, 3), it is likely that B10 and regulatory Foxp3 CD4 T cells share complementary regulatory functions for IBD, as previously shown for experimental autoimmune encephalomyelitis (29).”
BackgroundB Cells Exposed to Enterobacterial Components Suppress Development of Experimental Colitis
Schmidt, E., Larsen, H. L., Kristensen, N., Poulsen, S., Claesson, M., & Pedersen, A. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21769 · Cited by 25 · cited 2×
“Spleen B cells exposed to enterobacterial components can also acquire IL-10-dependent suppressive functions and inhibit experimental colitis (21).”
Background
Cited by
Sorted by citations
B cell regulation in cancer and anti-tumor immunity
Sarvaria, A., Madrigal, J. A., & Saudemont, A. (2017) · Cellular and Molecular Immunology · doi:10.1038/cmi.2017.35 · Cited by 652
Antibody-independent functions of B cells: a focus on cytokines
Shen, P., & Fillatreau, S. (2015) · Nature Reviews Immunology · doi:10.1038/nri3857 · Cited by 508
B cells responses and cytokine production are regulated by their immune microenvironment
Vazquez, M. I., Catalan-Dibene, J., & Zlotnik, A. (2015) · Cytokine · doi:10.1016/j.cyto.2015.02.007 · Cited by 421
“These data are reminiscent of animal studies where Breg cells have been shown to lead to the resolution of colitis in mice [88].”
BackgroundResultImmunosuppressive Mechanisms of Regulatory B Cells
Catalán, D., Mansilla, M. A., Ferrier, A., Soto, L., Oļeiņika, K., Aguillón, J. C., & Aravena, O. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.611795 · Cited by 429
“Besides, murine IL-10 Bregs can prevent the recruitment of neutrophils to the sites of inflammation in a model of colitis (42).”
BackgroundInfluentialB10 Cells: A Functionally Defined Regulatory B Cell Subset
Tedder, T. F. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401329 · Cited by 290
“Whether these regulatory activities and mechanisms of action are attributable to a single B cell subset or functionally diverse B cell populations during IBD is unresolved.”
BackgroundResultInfluentialSelf-citation
Metadata
- Authors
- Maseda, D., Candando, K. M., Smith, S. H., Kalampokis, I., Weaver, C. T., Plevy, S. E., Poe, J. C., & Tedder, T. F.
- Affiliations
- Department of Immunology, Duke University Medical Center , Durham, NC 27710
- Duke Medical Center (US)
- University of Alabama at Birmingham (US)
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Tedder, Thomas F
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-09-01
- Volume
- 191
- Issue
- 5
- Pages
- 2780-2795
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- PMC
- PMC3770313
- OpenAlex
- W2170857080
- Cited by
- 144
- References
- 73
- Citations by year
- 2026: 7 · 2025: 3 · 2024: 7 · 2023: 4 · 2022: 5 · 2021: 10 · 2020: 13 · 2019: 18 · 2018: 11 · 2017: 14 · 2016: 17 · 2015: 21 · 2014: 12 · 2013: 1
- FWCI
- 9.41
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (P30CA016086)
- National Institute of Allergy and Infectious Diseases (AI 057157, U54AI057157, U19AI056363, AI-56363)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK054452, R01DK054452)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Keywords
- regulatory B cells, B10 cells, peritoneal cavity, IL-10, colitis, B cell subsets, B cell receptor repertoire, commensal microbiota, neutrophil infiltration, inflammatory cytokines, gut immune homeostasis
- MeSH terms
- Animals, Colitis, Disease Models, Animal, Enzyme-Linked Immunosorbent Assay, Fluorescent Antibody Technique, Interferon-gamma, Male, Mice, Inbred C57BL, Peritoneal Cavity, CD4-Positive T-Lymphocytes, Lymphocyte Subsets, Interleukin-10, Mice, Knockout, Adoptive Transfer, Mice, B-Lymphocytes, Regulatory
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review